India, Aug. 12 -- The reason trials are taking shorter time is because developers are taking more risks
The world has been scrambling to develop a vaccine against the novel coronavirus SARS-CoV-2 - the virus that causes COVID-19 - for the last few months.
Russia has emerged a winner in the race. It has already registered the vaccine and is set to launch it in October. According to media reports, Sechenov University had successfully completed the clinical trials on humans in July.
Russia's vaccine is out in less than seven months since the viral genome was published in January 2020. Even the most optimistic estimate for vaccine development was a year.
While Russia's achievement is unprecedented in the history of vaccines, and therefore u...